This funding was provided to fund the vanguard phase of two clinical trials in stroke:

  1. The ‘TASTE’ trial of an alternative clot-dissolving medication, tenecteplase, given within the first few hours of stroke, 
  2. The ‘ACTIVATE’ trial of environmental enrichment in stroke rehabilitation to improve recovery after stroke. For both projects, progress has been good, and many of the key milestones have already been met (6 months into the 12 months funding): ‘TASTE’.  
Research Area 
Project type 
Year of funding